216 related articles for article (PubMed ID: 11218866)
1. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
[TBL] [Abstract][Full Text] [Related]
2. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
[TBL] [Abstract][Full Text] [Related]
3. [Study on third-type immunoliposomes loaded drugs and the targeting in vitro and in vivo].
Hou XP; Zhang YF; Xie SS; Hu X
Yao Xue Xue Bao; 2001 Jul; 36(7):539-42. PubMed ID: 12585089
[TBL] [Abstract][Full Text] [Related]
4. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
Nam SM; Kim HS; Ahn WS; Park YS
Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
[TBL] [Abstract][Full Text] [Related]
5. PEG-immunoliposome.
Maruyama K
Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
[TBL] [Abstract][Full Text] [Related]
6. In vivo targeting by liposomes.
Maruyama K
Biol Pharm Bull; 2000 Jul; 23(7):791-9. PubMed ID: 10919354
[TBL] [Abstract][Full Text] [Related]
7. Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol).
Suzuki S; Watanabe S; Masuko T; Hashimoto Y
Biochim Biophys Acta; 1995 Aug; 1245(1):9-16. PubMed ID: 7654771
[TBL] [Abstract][Full Text] [Related]
8. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model.
Tseng YL; Hong RL; Tao MH; Chang FH
Int J Cancer; 1999 Mar; 80(5):723-30. PubMed ID: 10048974
[TBL] [Abstract][Full Text] [Related]
9. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
Mori A; Kennel SJ; Huang L
Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
[TBL] [Abstract][Full Text] [Related]
10. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin.
Lundberg BB; Griffiths G; Hansen HJ
Int J Pharm; 2000 Sep; 205(1-2):101-8. PubMed ID: 11000546
[TBL] [Abstract][Full Text] [Related]
11. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells.
Allen TM; Brandeis E; Hansen CB; Kao GY; Zalipsky S
Biochim Biophys Acta; 1995 Jul; 1237(2):99-108. PubMed ID: 7632714
[TBL] [Abstract][Full Text] [Related]
12. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
13. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
14. Effect of lipid composition on incorporation of trastuzumab-PEG-lipid into nanoliposomes by post-insertion method: physicochemical and cellular characterization.
Golkar N; Tamaddon AM; Samani SM
J Liposome Res; 2016; 26(2):113-25. PubMed ID: 26023889
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
Harding JA; Engbers CM; Newman MS; Goldstein NI; Zalipsky S
Biochim Biophys Acta; 1997 Jul; 1327(2):181-92. PubMed ID: 9271260
[TBL] [Abstract][Full Text] [Related]
16. [In vitro and in vivo targeting therapy of immunoliposomes against human gastric cancer].
Xu L; Zhang XY; Zhang SY
Zhonghua Yi Xue Za Zhi; 1994 Feb; 74(2):83-6, 126. PubMed ID: 8069726
[TBL] [Abstract][Full Text] [Related]
17. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
Maruyama K; Kennel SJ; Huang L
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
[TBL] [Abstract][Full Text] [Related]
18. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
[TBL] [Abstract][Full Text] [Related]
19. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
Koning GA; Morselt HW; Velinova MJ; Donga J; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
Biochim Biophys Acta; 1999 Aug; 1420(1-2):153-67. PubMed ID: 10446299
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
